Upcoming event

Phase 3 MAGNITUDE study

2022-02-18

In this interview, Prof. Chi elaborates on the Phase 3 MAGNITUDE study, the design of this study, the BRCA1/2 vs overall BM+ cohort results and more. 

Tags: ASCO GU22